Alan List Selected Research

Alan List Research Topics

Disease

36	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 11/2004
13	Neoplasms (Cancer) 01/2021 - 12/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 01/2009
5	Neutropenia 01/2010 - 02/2005
5	Thrombocytopenia (Thrombopenia) 01/2009 - 02/2005
4	Anemia 03/2019 - 02/2005
4	Multiple Myeloma 01/2010 - 01/2005
3	Hematologic Neoplasms (Hematological Malignancy) 03/2019 - 01/2007
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019 - 09/2008
2	Cytopenia 08/2010 - 04/2010
2	Refractory Anemia with Excess of Blasts (RAEM) 08/2010 - 04/2010
2	Leukemia 08/2010 - 03/2007
1	Leukopenia 03/2019
1	Thrombocytosis (Thrombocythemia) 03/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Wilms Tumor (Wilm's Tumor) 07/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2014
1	Bone Marrow Failure Disorders 02/2011
1	Pathologic Complete Response 09/2010
1	Injection Site Reaction 08/2010
1	Disease Progression 08/2010
1	Refractory Anemia 08/2010
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2010
1	Venous Thromboembolism 01/2010
1	Inflammation (Inflammations) 10/2008
1	Leukocytosis (Pleocytosis) 09/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2007
1	Philadelphia Chromosome 04/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2006
1	Infections 07/2005
1	Necrosis 01/2005

Drug/Important Bio-Agent (IBA)

22	Lenalidomide (CC 5013)FDA Link 03/2019 - 02/2005
7	Azacitidine (5 Azacytidine)FDA Link 12/2017 - 05/2007
4	Biological ProductsIBA 03/2019 - 03/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2010 - 05/2007
4	Pharmaceutical PreparationsIBA 04/2010 - 11/2007
4	Immunomodulating AgentsIBA 01/2010 - 01/2005
3	CytokinesIBA 01/2019 - 03/2007
3	Thalidomide (Thalomid)FDA Link 01/2007 - 01/2005
2	Erythropoietin FDA Link 12/2017 - 02/2005
2	Phosphotransferases (Kinase)IBA 03/2015 - 04/2007
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	ImmunosorbentsIBA 12/2017
1	EnzymesIBA 12/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017
1	LipopolysaccharidesIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	HematinicsIBA 11/2015
1	WT1 ProteinsIBA 07/2015
1	sargramostim (Leukine)FDA Link 07/2015
1	AntigensIBA 07/2015
1	Peptides (Polypeptides)IBA 07/2015
1	Protein Subunit VaccinesIBA 07/2015
1	pexmetinibIBA 03/2015
1	p38 Mitogen-Activated Protein KinasesIBA 03/2015
1	LY-2157299IBA 02/2011
1	pomalidomideIBA 01/2010
1	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2009
1	gamma-Glu-S-BzCys-PhGly diethyl ester (T.199)IBA 06/2009
1	Glutathione (Reduced Glutathione)IBA 06/2009
1	ProdrugsIBA 06/2009
1	TabletsIBA 06/2009
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2007
1	tipifarnib (R115777)IBA 05/2007
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2007
1	Sirolimus (Rapamycin)FDA Link 05/2007
1	Decitabine FDA Link 05/2007
1	Imatinib Mesylate (Gleevec)FDA Link 04/2007
1	src-Family KinasesIBA 04/2007
1	Dasatinib (BMS 354825)FDA Link 04/2007
1	Angiogenic ProteinsIBA 03/2007
1	LigandsIBA 03/2007
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 03/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2005
1	Interleukin-12 (IL 12)IBA 01/2005
1	Histone Deacetylase InhibitorsIBA 12/2004
1	Hydroxamic Acids (Hydroxamic Acid)IBA 12/2004
1	MethyltransferasesIBA 11/2004

Therapy/Procedure

12	Therapeutics 01/2021 - 02/2005
3	Cell Transplantation 01/2018 - 06/2014
3	Drug Therapy (Chemotherapy) 08/2010 - 03/2009
1	Erythrocyte Transfusion 01/2017
1	Injections 07/2015
1	Combination Drug Therapy (Combination Chemotherapy) 05/2007
1	Immunomodulation 01/2006
1	Platelet Transfusion (Blood Platelet Transfusions) 07/2005
1	Drug Tapering 02/2005